Inhibition of intimal hyperplasia after balloon injury in rat carotid artery model using cis-element 'decoy' of nuclear factor-kB binding site as a novel molecular strategy

Gene Therapy

Volumn 8, Issue 21, 2001, Pages 1635-1642

  Yoshimura, S ^a   Morishita, R ^b,c   Hayashi, K ^a   Yamamoto, K ^c   Nakagami, H ^c   Kaneda, Y ^b   Sakai, N ^a   Ogihara, T ^c  

^a GIFU UNIVERSITY   (Japan)

^b OSAKA UNIVERSITY MEDICAL SCHOOL   (Japan)

^c OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Apoptosis; Decoy; Gene therapy; Nuclear factor kB; Restenosis

Indexed keywords

CELL ADHESION MOLECULE; CIS ACTING ELEMENT; CYTOKINE; DOUBLE STRANDED DNA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERCELLULAR ADHESION MOLECULE 1; OLIGONUCLEOTIDE; PROTEIN P53; SYNTHETIC DNA; VASCULAR CELL ADHESION MOLECULE 1;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTERY INTIMA; ARTERY INTIMA PROLIFERATION; ARTERY MEDIA; ARTICLE; ATHEROSCLEROSIS; BALLOON CATHETER; BINDING AFFINITY; BINDING SITE; CAROTID ARTERY INJURY; CONTROLLED STUDY; CORONARY ARTERY DILATATION; DOWN REGULATION; GENE ACTIVATION; GENE EXPRESSION; GENE TRANSFER; GENETIC TRANSFECTION; IN VIVO STUDY; INFLAMMATION; LYMPHOCYTE MIGRATION; MACROPHAGE MIGRATION INHIBITION; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; RAT; TRANSACTIVATION;

ANIMALS; APOPTOSIS; BALLOON DILATATION; BINDING SITES; CAROTID ARTERY INJURIES; CAROTID ARTERY, COMMON; GENE EXPRESSION; GENE THERAPY; GENES, P53; HYPERPLASIA; INTERCELLULAR ADHESION MOLECULE-1; MALE; MODELS, ANIMAL; NF-KAPPA B; PROTEIN BINDING; RATS; RATS, SPRAGUE-DAWLEY; TUNICA INTIMA; VASCULAR CELL ADHESION MOLECULE-1;

ANIMALIA;

EID: 0035190605     PISSN: 09697128     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.gt.3301566     Document Type: Article

References (43)

1. The emerging concept of vascular remodeling
2. Pharmacological approaches for the prevention of restenosis after percutaneous coronary intervention
3. Apoptosis: Basic mechanisms and implications for cardiovascular disease
4. Evidence for apoptosis in advanced human atheroma: Colocalization with interleukin-1β converting enzyme
5. Apoptosis of human vascular smooth muscle cells derived from normal vessels and coronary atherosclerotic plaques
6. Evidence for apoptosis in human atherogenesis and in a rat vascular injury model
7. Apoptosis in human atherosclerosis and restenosis
8. The role of infection in restenosis: Focus on cytomegalovirus
9. Nuclear factor-kappa B contributes to excitotoxin-induced apoptosis in rat striatum
10. NF-kappaB antiapoptosis: Induction of TRAF1 and TRAF2 and c-IAP1 and c-IAP2 to suppress caspase-8 activation
11. The nuclear factor-κB signaling pathway participates in dysregulation of vascular smooth muscle cells in vitro and in human atherosclerosis
12. Activated transcription factor nuclear factor-κB is present in the atherosclerotic lesion
13. Activation of the NF-κB and I-κB system in smooth muscle cells after rat arterial injury: Induction of vascular cell adhesion molecule-1 and monocyte chemotactic protein-1
14. Nuclear factor-κB activity and arterial response to balloon injury
15. Expression of a constitutive NF-κB-like activity is essential for proliferation of cultured bovine smooth muscle cells
16. Liposomal delivery of purified inhibitory-κBα inhibits tumor necrosis factor-α-induced human vascular smooth muscle proliferation
17. Nuclear factor-κB regulates induction of apoptosis and inhibitor of apoptosis protein-1 expression in vascular smooth muscle cells
18. Aspirin inhibits nuclear factor-κB mobilization and monocyte adhesion in stimulated human endothelial cells
19. Antioxidants inhibit monocyte adhesion by suppressing nuclear factor-κB mobilization and induction of vascular cell adhesion molecule 1 in endothelial cells stimulated to generate radicals
20. Transcriptional regulation of the intercellular adhesion molecule-1 gene by inflammatory cytokines in human endothelial cells
21. Inhibition of intimal hyperplasia after balloon injury by antibodies to intercellular adhesion molecule-1 and lymphocyte function-associated antigen-1
22. Strategy for functional inactivation of genes: A novel strategy for gene therapy and gene regulation analysis using transcriptional factor decoy oligonucleotides
23. Application of transcription factor 'decoy' strategy as means of gene therapy and study of gene expression in cardiovascular disease
24. In vivo transfection of cis element 'decoy' against nuclear factor-κB binding site prevents myocardial infarction
25. Sustained activation of vascular cells and leukocytes in the rabbit aorta after balloon injury
26. CREB-binding protein is a nuclear integrator of nuclear factor-kappaB and p53 signaling
27. The inducible transcription factor NF-κB: Structure-function relationship of its protein subunits
28. Endothelial nuclear factor-κB and the initiation of atheroscrelotic lesion
29. Intramolecular masking of the nuclear location signal and dimerization domain in the precursor for the p50 NF-κB subunit
30. Rapid proteolysis of IκBα is necessary for activation of transcription factor NF-κB
31. Vascular smooth muscle cells express a constitutive NF-κB-like activity
32. Transcription factor decoy for NFkB inhibits TNF-α-induced IL-6 and ICAM-1 expression in endothelial cells
33. Apoptosis of rat vascular smooth muscle cells is regulated by p53-dependent and -independent pathways
34. Inhibition of the p53 tumor suppressor gene resulted in growth of human aortic vascular smooth muscle cells (VSMC): Potential role of p53 in regulation of VSMC growth
35. p53, guardian of the genome
36. Identification of a p53-dependent negative response element in the bcl-2 gene
37. Tumor suppressor p53 is a direct transcriptional activator of the human bax gene
38. Apoptosis mediates the decrease in cellularity during the transition between granulation tissue and scar
39. Role of AP-1 complex in angiotensin II-mediated transforming growth factor-β expression and growth of smooth muscle cells using decoy approach against AP-1 binding site
40. Novel intraluminal molecular delivery of antisense cdc2 kinase and PCNA oligonucleotide results in chronic inhibition of neointimal hyperplasia
41. Intimal hyperplasia after vascular injury is inhibited by antisense cdk 2 kinase oligonucleotides
42. Increased expression of DNA cointroduced with nuclear protein in adult rat liver
43. Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation